According to EurekAlert, the American scientists from the Californian University have developed a method that allows to detect non-small cell lung carcinoma (a type of lung cancer). Previously, the disease specialists can only be determined at a later stage, the researchers now propose to diagnose the disease at an early stage by using saliva or blood.
Scientists developed a new technology EFIRM can detect two marker mutations of the epidermal cells and growth of tumors – p.L858R and Exon 19del. Testing of this method showed that it allows to precisely determine non-small cell lung carcinoma in 11 of 12 patients. The experts stated that technology EFIRM could save the lives of thousands of people. Still effective diagnostics of the disease in the early stages was absent, and tumors are often discovered at a time when stopping the spread of cancer will not help and surgical intervention.
Small cell carcinoma is the most common form of lung cancer, often fatal to patients: survival for 5 years after chemotherapy is not more than 10%. In this study, the researchers studied data from 248 patients who were found some lung tumors. Using this new approach, the 21-person team was able to identify non-small cell lung carcinoma lung first and second stage.
The researchers emphasize new diagnostic method allows to detect cancer even at an operable stage.
Earlier Magicforum wrote that popular sweets contain the additive, capable to provoke the development of cancer.